Details

Autor(en) / Beteiligte

• van Leeuwen, Otto B.
• Bodewes, Silke B.
• Lantinga, Veerle A.
• Haring, Martijn P.D.
• Thorne, Adam M.
• Brüggenwirth, Isabel M.A.
• van den Berg, Aad P.
• de Boer, Marieke T.
• de Jong, Iris E.M.
• de Kleine, Ruben H.J.
• Lascaris, Bianca
• Nijsten, Maarten W.N.
• Reyntjens, Koen M.E.M.
• de Meijer, Vincent E.
• Porte, Robert J.

Titel

Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high‐risk donor livers

Ist Teil von

• American journal of transplantation, 2022-06, Vol.22 (6), p.1658-1670

Ort / Verlag

United States: Wiley Subscription Services, Inc

Erscheinungsjahr

2022

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Ex situ normothermic machine perfusion (NMP) is increasingly used for viability assessment of high‐risk donor livers, whereas dual hypothermic oxygenated machine perfusion (DHOPE) reduces ischemia‐reperfusion injury. We aimed to resuscitate and test the viability of initially‐discarded, high‐risk donor livers using sequential DHOPE and NMP with two different oxygen carriers: an artificial hemoglobin‐based oxygen carrier (HBOC) or red blood cells (RBC). In a prospective observational cohort study of 54 livers that underwent DHOPE‐NMP, the first 18 procedures were performed with a HBOC‐based perfusion solution and the subsequent 36 procedures were performed with an RBC‐based perfusion solution for the NMP phase. All but one livers were derived from extended criteria donation after circulatory death donors, with a median donor risk index of 2.84 (IQR 2.52–3.11). After functional assessment during NMP, 34 livers (63% utilization), met the viability criteria and were transplanted. One‐year graft and patient survival were 94% and 100%, respectively. Post‐transplant cholangiopathy occurred in 1 patient (3%). There were no significant differences in utilization rate and post‐transplant outcomes between the HBOC and RBC group. Ex situ machine perfusion using sequential DHOPE‐NMP for resuscitation and viability assessment of high‐risk donor livers results in excellent transplant outcomes, irrespective of the oxygen carrier used. Sequential end‐ischemic hypothermic and normothermic machine perfusion results in safe transplantation of previously discarded, high‐risk, human donor livers, irrespective of the oxygen carrier used for normothermic perfusion.